Form 8-K - Current report:
SEC Accession No. 0000950170-25-080986
Filing Date
2025-06-03
Accepted
2025-06-03 16:30:27
Documents
10
Period of Report
2025-05-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K rgnx-20250530.htm   iXBRL 8-K 69993
  Complete submission text file 0000950170-25-080986.txt   173169

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rgnx-20250530.xsd EX-101.SCH 23873
12 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-20250530_htm.xml XML 4522
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 251020082
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)